129 related articles for article (PubMed ID: 15173095)
1. Noninvasive measurements of capecitabine metabolism in bladder tumors overexpressing thymidine phosphorylase by fluorine-19 magnetic resonance spectroscopy.
Chung YL; Troy H; Judson IR; Leek R; Leach MO; Stubbs M; Harris AL; Griffiths JR
Clin Cancer Res; 2004 Jun; 10(11):3863-70. PubMed ID: 15173095
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of sensitivity to capecitabine in human renal carcinoma cells transfected with thymidine phosphorylase cDNA.
Morita T; Matsuzaki A; Tokue A
Int J Cancer; 2001 May; 92(3):451-6. PubMed ID: 11291085
[TBL] [Abstract][Full Text] [Related]
3. Gene expression predicts differential capecitabine metabolism, impacting on both pharmacokinetics and antitumour activity.
Guichard SM; Macpherson JS; Mayer I; Reid E; Muir M; Dodds M; Alexander S; Jodrell DI
Eur J Cancer; 2008 Jan; 44(2):310-7. PubMed ID: 18077151
[TBL] [Abstract][Full Text] [Related]
4. The Hollow Fibre Assay as a model for in vivo pharmacodynamics of fluoropyrimidines in colon cancer cells.
Temmink OH; Prins HJ; van Gelderop E; Peters GJ
Br J Cancer; 2007 Jan; 96(1):61-6. PubMed ID: 17179993
[TBL] [Abstract][Full Text] [Related]
5. IFN gamma-induced up-regulation of PD-ECGF/TP enhances the cytotoxicity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in bladder cancer cells.
Li G; Kawakami S; Kageyama Y; Yan C; Saito K; Kihara K
Anticancer Res; 2002; 22(5):2607-12. PubMed ID: 12529971
[TBL] [Abstract][Full Text] [Related]
6. The effect of fluoropyrimidines with or without thymidine phosphorylase inhibitor on the expression of thymidine phosphorylase.
De Bruin M; Van Capel T; Smid K; Fukushima M; Hoekman K; Pinedo HM; Peters GJ
Eur J Pharmacol; 2004 May; 491(2-3):93-9. PubMed ID: 15140625
[TBL] [Abstract][Full Text] [Related]
7. Quantitative 19F MR spectroscopy at 3 T to detect heterogeneous capecitabine metabolism in human liver.
Klomp D; van Laarhoven H; Scheenen T; Kamm Y; Heerschap A
NMR Biomed; 2007 Aug; 20(5):485-92. PubMed ID: 17131325
[TBL] [Abstract][Full Text] [Related]
8. The predictive and therapeutic value of thymidine phosphorylase and dihydropyrimidine dehydrogenase in capecitabine (Xeloda)-based chemotherapy for head and neck cancer.
Saito K; Khan K; Yu SZ; Ronson S; Rhee J; Li G; Van Echo D; Suntharalingam M; O'Malley BW; Li D
Laryngoscope; 2009 Jan; 119(1):82-8. PubMed ID: 19117293
[TBL] [Abstract][Full Text] [Related]
9. Role of platelet derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity and potential role of deoxyribose-1-phosphate.
de Bruin M; van Capel T; Smid K; van der Born K; Fukushima M; Hoekman K; Pinedo HM; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1485-90. PubMed ID: 15571282
[TBL] [Abstract][Full Text] [Related]
10. Optimized blood sampling with cytidine deaminase inhibitor for improved analysis of capecitabine metabolites.
Besnard T; Renée N; Etienne-Grimaldi MC; François E; Milano G
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(1):117-20. PubMed ID: 18562256
[TBL] [Abstract][Full Text] [Related]
11. Forced expression of cytidine deaminase confers sensitivity to capecitabine.
Morita T; Matsuzaki A; Kurokawa S; Tokue A
Oncology; 2003; 65(3):267-74. PubMed ID: 14657601
[TBL] [Abstract][Full Text] [Related]
12. Activity and substrate specificity of pyrimidine phosphorylases and their role in fluoropyrimidine sensitivity in colon cancer cell lines.
Temmink OH; de Bruin M; Turksma AW; Cricca S; Laan AC; Peters GJ
Int J Biochem Cell Biol; 2007; 39(3):565-75. PubMed ID: 17098463
[TBL] [Abstract][Full Text] [Related]
13. Interferon-alpha 2a up-regulated thymidine phosphorylase and enhanced antitumor effect of capecitabine on hepatocellular carcinoma in nude mice.
Xiao YS; Tang ZY; Fan J; Zhou J; Wu ZQ; Sun QM; Xue Q; Zhao Y; Liu YK; Ye SL
J Cancer Res Clin Oncol; 2004 Sep; 130(9):546-50. PubMed ID: 15071737
[TBL] [Abstract][Full Text] [Related]
14. Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabine.
Ko JC; Tsai MS; Kuo YH; Chiu YF; Weng SH; Su YC; Lin YW
Biochem Pharmacol; 2011 Mar; 81(5):680-90. PubMed ID: 21168393
[TBL] [Abstract][Full Text] [Related]
15. In vivo monitoring of capecitabine metabolism in human liver by 19fluorine magnetic resonance spectroscopy at 1.5 and 3 Tesla field strength.
van Laarhoven HW; Klomp DW; Kamm YJ; Punt CJ; Heerschap A
Cancer Res; 2003 Nov; 63(22):7609-12. PubMed ID: 14633676
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: up-regulation of thymidine phosphorylase.
Saif MW; Black G; Roy S; Bell D; Russo S; Eloubeidi MA; Steg A; Johnson MR; Zelterman D; Diasio RB
Cancer J; 2007; 13(4):247-56. PubMed ID: 17762760
[TBL] [Abstract][Full Text] [Related]
17. Erlotinib in combination with capecitabine (5'dFUR) in resistant pancreatic cancer cell lines.
Chefrour M; Fischel JL; Formento P; Giacometti S; Ferri-Dessens RM; Marouani H; Francoual M; Renée N; Mercier C; Milano G; Ciccolini J
J Chemother; 2010 Apr; 22(2):129-33. PubMed ID: 20435574
[TBL] [Abstract][Full Text] [Related]
18. Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity.
de Bruin M; van Capel T; Van der Born K; Kruyt FA; Fukushima M; Hoekman K; Pinedo HM; Peters GJ
Br J Cancer; 2003 Mar; 88(6):957-64. PubMed ID: 12644837
[TBL] [Abstract][Full Text] [Related]
19. Prediction of the effect of capecitabine in gastric cancer by immunohistochemical staining of thymidine phosphorylase and dihydropyrimidine dehydrogenase.
Koizumi W; Okayasu I; Hyodo I; Sakamoto J; Kojima H;
Anticancer Drugs; 2008 Sep; 19(8):819-24. PubMed ID: 18690094
[TBL] [Abstract][Full Text] [Related]
20. Diurnal Changes in Capecitabine Clock-Controlled Metabolism Enzymes Are Responsible for Its Pharmacokinetics in Male Mice.
Akyel YK; Ozturk Civelek D; Ozturk Seyhan N; Gul S; Gazioglu I; Pala Kara Z; Lévi F; Kavakli IH; Okyar A
J Biol Rhythms; 2023 Apr; 38(2):171-184. PubMed ID: 36762608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
